Clinical Trial Update: Neurohormonal Parameters in Hypertrophic Cardiomyopathies [NA]

View source ↗

Summary

This completed clinical trial assessed neurohormonal parameters across primary sarcomeric, obstructive, and non-obstructive hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: French Cardiology Society | Conditions: 1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy, 2- Obstructive Hypertrophic Cardiomyopathy | NA | Status: COMPLETED